ALCAM Deficiency Alleviates LPS-Induced Acute Lung Injury by Inhibiting Inflammatory Response

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..

We investigated the effects and underlying mechanisms of activated leukocyte adhesion molecule (ALCAM) on acute lung injury (ALI) by using lipopolysaccharide (LPS)-induced ALI animal model and LPS-induced inflammation in vitro. In LPS-stimulated mice, ALCAM deficiency relieved lung injury, which manifested as reduced pathological changes in the lung tissue, reduced pulmonary edema, and reduced vascular permeability. Furthermore, we demonstrated that ALCAM deficiency reduced the infiltration of inflammatory cells, including neutrophil, eosinophil, and macrophages; the release of inflammatory cytokines, including IL-1β, IL-6, TNF-α, and COX2; and reduced the protein level of TLR4/NF-κB pathway (TLR4, MyD88, p-IkBɑ, and p-NF-κB p65). We also demonstrated that ALCAM deficiency reduced the expression of oxidative stress-related proteins (Nrf-2, HO-1, and NQO-1) and endoplasmic reticulum stress-related proteins (CHOP, GRP78, ATF-6, and p-eIF2ɑ). In addition, in LPS-induced inflammation in vitro, ALCAM overexpression promoted inflammatory response, oxidative stress, and ER stress. We established that ALCAM deficiency can suppress the ALI process by reducing inflammatory response, oxidative stress, and endoplasmic reticulum stress.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:46

Enthalten in:

Inflammation - 46(2023), 2 vom: 24. Apr., Seite 688-699

Sprache:

Englisch

Beteiligte Personen:

Li, Ruirui [VerfasserIn]
Ren, Tao [VerfasserIn]
Zeng, Jianqiong [VerfasserIn]
Xu, Hang [VerfasserIn]

Links:

Volltext

Themen:

Activated leukocyte adhesion molecule
Activated-Leukocyte Cell Adhesion Molecule
Acute lung injury
Endoplasmic reticulum stress
Inflammatory response
Journal Article
Lipopolysaccharides
NF-kappa B
Oxidative stress
Toll-Like Receptor 4

Anmerkungen:

Date Completed 21.03.2023

Date Revised 21.03.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1007/s10753-022-01765-3

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM349318549